{'fraction_non_alphanumeric': 0.021780303030303032, 'fraction_numerical': 0.004734848484848485, 'mean_word_length': 4.622340425531915, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A Case of Chemical Restraint

THIS is a case study illustrating the inappropriate use of antipsychotic medication to deliberately sedate a patient to produce a chemical restraint. The patient was an 80-year-old woman who sustained damage to the hippocampus region of the brain 2 years earlier, secondary to a drug-drug interaction. The patient did not suffer any paralysis but did experience severe short-term memory loss. The patient’s medical history was significant for hypertension, high cholesterol, deep vein thrombosis (DVT), and spinal stenosis. Prior to this infarction, the patient was active, playing golf and tennis several times a week. Shortly after the memory loss, the patient was a passenger in a car driven by her 91-yearold male friend when the car was driven off a road and up onto a curb. The patient got out of the car to check for damage when the driver inadvertently stepped on the gas pedal and hit the patient with his car. The patient sustained a stress fracture to the sacrum and further aggravation of her spinal stenosis. From